Showing results (61-70 of 239) with videos related to

Sort By:
Pageof 24
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 20, 2014
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophreniaDaniel Umbricht, Richard S E Keefe, Stephen Murray, et al.
Biological Psychiatry|January 11, 2007
Risperidone and cognitive function in children with disruptive behavior disordersGahan J Pandina, Robert Bilder, Philip D Harvey, et al.
The Clinical Neuropsychologist|February 1, 2013
Applicability of the MATRICS Consensus Cognitive Battery in SingaporeAttilio Rapisarda, Thomas F Lim, Matthew Lim, et al.
Schizophrenia Bulletin|October 17, 2017
Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk PredictionKristin M Healey, David L Penn, Diana Perkins, et al.
Psychological Medicine|April 19, 2016
The relationship between negative symptom subdomains and cognitionJ Lim, S-A Lee, M Lam, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 17, 2007
Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patientsMarie-Cécile Bralet, Bruno Falissard, Xavier Neveu, et al.
Schizophrenia Bulletin|April 23, 2010
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?Robert W Buchanan, Richard S E Keefe, Daniel Umbricht, et al.
The Journal of Clinical Psychiatry|August 8, 2014
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic reviewRichard S E Keefe, Shawn M McClintock, Robert M Roth, et al.
Schizophrenia Research|October 15, 2013
Unraveling the relationship between obesity, schizophrenia and cognitionNur Amirah Abdul Rashid, Jeanette Lim, Max Lam, et al.
Pageof 24